← Eichor
Condition: Cancer Cachexia Syndrome Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cancer Cachexia Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464Olanzapine for Cancer Related Anorexia-cachexia Syndrome
Phase 3 · 2 location(s) · Mahidol University · NCT06517199Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative
Phase 3 · 1 location(s) · Blokhin's Russian Cancer Research Center · NCT07633236Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer
NA · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07408505Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG)
Phase N/A · 1 location(s) · University of Cambridge · NCT06112964A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy
Phase 1 · 1 location(s) · Jiangsu Nutai Biologics Co., Ltd · NCT07231120Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Phase N/A · 2 location(s) · Wake Forest University Health Sciences · NCT05376592
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.